The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
. Survival of persons with and without HIV infection in Denmark, 1995-2005.
Abstract
BACKGROUND: The expected survival of HIV-infected patients is of major public health interest. OBJECTIVE: To estimate survival time and age-specific mortality rates of an HIV-infected population compared with that of the general population. DESIGN: Population-based cohort study. SETTING: All HIV-infected persons receiving care in Denmark from 1995 to 2005. PATIENTS: Each member of the nationwide Danish HIV Cohort Study was matched with as many as 99 persons from the general population according to sex, date of birth, and municipality of residence. MEASUREMENTS: The authors computed Kaplan-Meier life tables with age as the time scale to estimate survival from age 25 years. Patients with HIV infection and corresponding persons from the general population were observed from the date of the patient's HIV diagnosis until death, emigration, or 1 May 2005. RESULTS: 3990 HIV-infected patients and 379,872 persons from the general population were included in the study, yielding 22,744 (median, 5.8 y/person) and 2,689,287 (median, 8.4 years/person) person-years of observation. Three percent of participants were lost to follow-up. From age 25 years, the median survival was 19.9 years (95% CI, 18.5 to 21.3) among patients with HIV infection and 51.1 years (CI, 50.9 to 51.5) among the general population. For HIV-infected patients, survival increased to 32.5 years (CI, 29.4 to 34.7) during the 2000 to 2005 period. In the subgroup that excluded persons with known hepatitis C coinfection (16%), median survival was 38.9 years (CI, 35.4 to 40.1) during this same period. The relative mortality rates for patients with HIV infection compared with those for the general population decreased with increasing age, whereas the excess mortality rate increased with increasing age. LIMITATIONS: The observed mortality rates are assumed to apply beyond the current maximum observation time of 10 years. CONCLUSIONS: The estimated median survival is more than 35 years for a young person diagnosed with HIV infection in the late highly active antiretroviral therapy era. However, an ongoing effort is still needed to further reduce mortality rates for these persons compared with the general population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is an emerging consensus in the scientific community that HIV infection hastens the process of aging and that illnesses that appear typically in the elderly are highly frequent among HIV-infected individuals, even in those with therapy-induced suppression of the virus below detection limits [59,60].”
From T-cell aging in rheumatoid arthritis (2014) · cites this paper as [59]
In the citing paper
“When compared to behaviorally and demographically similar HIV-uninfected individuals, people with HIV infection, even those receiving effective ART with suppression of virus to levels below typical detection limits, experience excess morbidity and mortality (3,4).”
Citations
Cites
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., Monforte, A. D., Knysz, B., Dietrich, M., Phillips, A. N., & Lundgren, J. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13802-0 · Cited by 1,241
When an Entire Country Is a Cohort
Frank, L. (2000) · Science · doi:10.1126/science.287.5462.2398 · Cited by 865
Galván, F. H., Bing, E. G., Fleishman, J. A., London, A. S., Caetano, R., Burnam, M. A., Longshore, D. L., Morton, S. C., Orlando, M., & Shapiro, M. F. (2002) · Journal of Studies on Alcohol · doi:10.15288/jsa.2002.63.179 · Cited by 438
Laing, S. P., Swerdlow, A. J., Slater, S. D., Botha, J. L., Burden, A. C., Waugh, N. R., Smith, A. W. M., Hill, R. D., Bingley, P. J., Patterson, C. C., et al. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00075.x · Cited by 427
Savès, M., Chêne, G., Ducimetière, P., Leport, C., Moal, G. L., Amouyel, P., Arveiler, D., Ruidavets, J., Reynes, J., Bingham, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375844 · Cited by 399
Cigarette Smoking and the Desire to Quit Among Individuals Living with HIV
Mamary, E. M., Bahrs, D., & Martinez, S. A. (2002) · AIDS Patient Care and STDs · doi:10.1089/108729102753429389 · Cited by 155
UK CHIC Study Group The UK Collaborative Group on HIV Drug Resistance (2005) · AIDS · doi:10.1097/01.aids.0000162337.58557.3d · Cited by 149
Estimating the proportion of patients infected with HIV who will die of comorbid diseases
Braithwaite, R. S., Justice, A. C., Chang, C. H., Fusco, J. S., Raffanti, S. R., Wong, J. B., & Roberts, M. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.034 · Cited by 136
Lundgren, J. D., Mocroft, A., Gatell, J. M., Ledergerber, B., Monforte, A. D., Hermans, P., Goebel, F., Blaxhult, A., Kirk, O., Phillips, A. N., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338267 · Cited by 129
Press, N., TYNDALL, M. W., Wood, E., Hogg, R. S., & Montaner, J. S. G. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200212153-00005 · Cited by 116
Research works printed but not linked: 1
- Christensen PB, 1998, Ugeskr Laeger, 160, 3529
Cited by
Sorted by citations
Items 601–700 of 748
Essential medical issues related to HIV in dentistry.
Moswin, A., & Epstein, J. B. (2007) · PubMed · Cited by 3
[Advances and challenges for the prevention and control of AIDS in Mexico].
Licea, J. A. I., Magis-Rodríguez, C. L., Bravo-García, E., Mondragón, R. O., Rivera-Reyes, P., & de León, C. G. (2010) · PubMed · Cited by 3
Rodkjær, L. Ø. (2014) · Journal of HIV for Clinical and Scientific Research · doi:10.17352/2455-3786.000003 · Cited by 3
Pollock, K. M., Pintilie, H., Foster, C., & Fidler, S. J. (2018) · Medicine · doi:10.1097/md.0000000000009798 · Cited by 3
Schanzer, D. L., Antoniou, T., Kwong, J. C., Timmerman, K., & Yan, P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195031 · Cited by 3
Future of HIV/AIDS Care in Low- and Middle- Income Countries
Hoffmann, C. J., Mills, L. A., & Gallant, J. E. (2008) · Springer eBooks · doi:10.1007/978-0-387-72711-0_3 · Cited by 3
HIV-associated kidney diseases: progress, gaps, and future directions
Fisher, M. C., Wyatt, C. M., & Estrella, M. M. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00207-25 · Cited by 3
Cerebrospinal fluid markers of alzheimer’s pathology relate to aMCI among people with HIV
Lobo, J. D., Serrano, V. B., Campbell, L. M., Bell, T., Gouaux, B. D., Galasko, D. R., Letendre, S. L., Bondi, M. W., Moore, D. J., & Sundermann, E. E. (2026) · BMC Neurology · doi:10.1186/s12883-025-04585-8 · Cited by 2
Assessment and Modification of Cardiovascular Disease Risk in the HIV-Infected Individual
Ross, A. C., & McComsey, G. A. (2011) · Future Virology · doi:10.2217/fvl.11.8 · Cited by 2
Weissman, S., Singh, S. A., Dykema, S., & Parker, D. R. (2016) · Journal of Community Health · doi:10.1007/s10900-016-0188-4 · Cited by 2
Desarrollo de un programa de paciente experto 2.0 para pacientes VIH
Morillo‐Verdugo, R., & Ma, R.-C. (2015) · Revista Multidisciplinar del Sida · Cited by 2
Impact of HIV infection on cardiac deformation
Mendes, L., Silva, D., Miranda, C. P., Sá, J., Duque, L., Duarte, N., de Brito, P. M., Bernardino, L., & Poças, J. (2014) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2013.12.006 · Cited by 2
Álvarez-Álvarez, B., Prieto-Pérez, L., de la Cuadra-Grande, A., Casado, M. Á., Cabello, A., Al‐Hayani, A., Acosta, I. C., Mahíllo, I., Hernández-Mora, M. G., Rallón, N., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133936 · Cited by 2
[Impact of long-term highly active antiretroviral therapy on bone metabolism in AIDS patients].
Jufeng, W., Lijun, X. U., Ying, H., Yirui, X., Sun, J., Junwei, S. U., & Zhu, B. (2016) · PubMed Central · doi:10.3785/j.issn.1008-9292.2016.05.02 · Cited by 2
CD8+ T cell expansion in HIV/HCV coinfection is associated with systemic inflammation
Сайдакова, Е. В., Владимирович, Ш. К., Korolevskaya, L. B., Геннадьевна, Ш. Н., & Черешнев, В. А. (2017) · Doklady Biological Sciences · doi:10.1134/s0012496617030024 · Cited by 2
Petroll, A. E., Phelps, J. K., & Fletcher, K. E. (2014) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2013.12.005 · Cited by 2
Defining Success With Antiretroviral Therapy
Schacker, T. W. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.4004 · Cited by 2
Highly active anti-hepatitis C therapy: seven lessons from HIV
Thomas, D. L. (2012) · Antiviral Therapy · doi:10.3851/imp2429 · Cited by 2
Rogowska-Szadkowska, D., Kozłowski, A., & Marzec-Bogusławska, A. (2008) · HIV & AIDS Review · doi:10.1016/s1730-1270(10)60018-5 · Cited by 2
Routine Screening for HIV Infection in a Low Risk Population
Bessesen, M. T., Stamper, P., Shaw, J., Ojha, N., Currans, A., Weinshenker, D., & Merrick, D. T. (2012) · Advances in Infectious Diseases · doi:10.4236/aid.2012.22004 · Cited by 2
An HIV Patient with Hepatic Flare after the Initiation of HBV-active Antiretroviral Therapy
Yoshida, M., Hoshina, T., Tamura, K., Kawano, S., Kato, T., Sato, F., Nakazawa, Y., Yoshikawa, K., Onodera, S., & Hori, S. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.7244 · Cited by 2
Stephan, C. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.734296 · Cited by 2
Electrochemical and Spectrometric Study of GFP-AZT Interaction
Zítka, O., Kynický, J., Komínková, M., Kenšová, R., Guráň, R., Trnková, L., Adam, V., & Kizek, R. (2014) · International Journal of Electrochemical Science · doi:10.1016/s1452-3981(23)08020-3 · Cited by 2
Wafai, N. A., Zafar, K. S., Kumar, M. T., Singh, P. S., & Yadav, S. K. (2016) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20163291 · Cited by 2
Antibiotika und Chemotherapeutika
Kern, W. V. (2009) · Springer eBooks · doi:10.1007/978-3-642-01080-4_9 · Cited by 2
Antibiotika und Chemotherapeutika
Kern, W. V. (2017) · Springer eBooks · doi:10.1007/978-3-662-54630-7_12 · Cited by 2
Living and Working with HIV/AIDS: A Lifelong Process of Adaptation
Samson, A., & Siam, H. (2011) · InTech eBooks · doi:10.5772/19497 · Cited by 2
Incidence of benign prostate hypertrophy in Danish men with and without HIV infection
Ahlström, M. G., Kronborg, G., Larsen, C. S., Pedersen, C., Pedersen, G., Gerstoft, J., & Obel, N. (2015) · AIDS · doi:10.1097/qad.0000000000000804 · Cited by 2
Self-citationLin, C. A., Behrens, P. H., Paiement, G. D., Hardy, W. D., Mirocha, J., Rettig, R. L., Kiziah, H. L., Rudikoff, A. G., & Conte, A. H. (2020) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-020-01827-y · Cited by 2
Significant Challenges Facing HIV Practitioners
Bartlett, J. G. (2008) · The Journal of Infectious Diseases · doi:10.1086/533417 · Cited by 2
Moreno, S. (2016) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2016.01.001 · Cited by 2
Siegel, D. A., Thanh, C., Wan, E., Hoh, R., Hobbs, K. S., Pan, T., Gibson, E. A., Kroetz, D. L., Hunt, P. W., Martin, J. N., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.31.466670 · Cited by 2
Rail guns driven by helical flux compression generators
Fowler, C. M., Zimmermann, E., Cummings, C., Davidson, R. F., Foley, E., Fox, W., Kerrisk, J. F., Parker, J. V., Parson, W. M., & Schnurr, N. M. (1986) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 2
Oka, S. (2015) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.104.1885 · Cited by 1
Point prevalence of metabolic syndrome in HIV positive patients
Hamid, S., Badyal, A., & Sumberia, V. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1237_23 · Cited by 1
Hunt, P. W., Olshen, A. B., Murad, N. F., Ambayec, G. C., Sezgın, E., Schneider, M. F., & Jabs, D. A. (2025) · Ophthalmology Science · doi:10.1016/j.xops.2025.100794 · Cited by 1
Klastrup, V., Gunst, J. D., & Søgaard, O. S. (2025) · Journal of Virus Eradication · doi:10.1016/j.jve.2025.100604 · Cited by 1
Cross‐sectional comparison of cardiovascular risk scores in people with HIV
Hernandez‐Pereira, M., Du, J., Soldado‐Folgado, J., Carbonell, I., Trenchs‐Rodríguez, M., González‐Mena, A., García‐Giralt, N., & Güerri‐Fernández, R. (2025) · HIV Medicine · doi:10.1111/hiv.70152 · Cited by 1
Endothelial Dysfunction in HIV
Subbarao, V., Lowe, D. M., Aghamohammadzadeh, R., & Robert, J. (2011) · InTech eBooks · doi:10.5772/23048 · Cited by 2
Mínguez‐Gallego, C., Vera-Remartínez, E. J., Albert-Coll, M., Roldán-Puchalt, M. C., Aguilar-Climent, M., Rovira-Ferrando, R. E., Andrés-Soler, J., Roig-Espert, B., Penadés-Vidal, M., & Blasco, J. U. (2014) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2014.04.012 · Cited by 1
Oral antiretroviral therapy for the prevention of HIV-1 infection: ready for prime time?
Hull, M., & Montaner, J. S. G. (2011) · Clinical Investigation · doi:10.4155/cli.11.160 · Cited by 1
Molecular Bases of Osteoporosis in HIV: The Role of the Virus and Antiretroviral Therapy
Gibellini, D., Borderi, M., Vanino, E., Clò, A., Morini, S., Calza, L., Re, M. C., & Viale, P. (2012) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-012-9133-y · Cited by 1
Abacavir/Lamivudine Fixed Dose Combination in the Treatment of Patients with HIV Infection
Anderson, A. M. L., & Lennox, J. L. (2008) · HIV Therapy · doi:10.2217/17584310.3.1.19 · Cited by 1
Myalgia and creatine phosphokinase elevations in the HAART era: focus on Raltegravir
Madeddu, G., Soddu, V., Fiori, M. L., Caddeo, A., & Mura, M. S. (2011) · Cited by 1
Morbidität und Mortalität der HIV-Infektion
Stöckle, M., Elzi, L., Rockstroh, J. K., & Battegay, M. (2012) · Der Internist · doi:10.1007/s00108-011-2990-5 · Cited by 1
Human Immunodeficiency Viruses Types 1 and 2
Kaslow, R. A., Erbelding, E. J., & Goepfert, P. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7448-8_43 · Cited by 2
Secondary complications and co-infections in the HIV-infected adolescent in the antiretroviral era
Ross, A. C., Camacho-González, A., Chahroudi, A., & Chakraborty, R. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283460d34 · Cited by 1
A Review of Arterial Stiffness and HIV Infection in Adult Africans
Awotedu, K. O., & Iputo, J. E. (2016) · Journal of Hypertension Open Access · doi:10.4172/2167-1095.1000221 · Cited by 1
Kunimoto, Y., Yoshino, M., Ohishi, Y., Harada, S., Inoue, M., Sato, M., Uchiyama, M., Saito, N., Maruyama, I., Shimokawa, C., et al. (2014) · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · doi:10.5649/jjphcs.40.471 · Cited by 1
Kulikov, A. Y., & Babiy, V. V. (2015) · Pharmacoeconomics theory and practice · doi:10.30809/phe.1.2015.35 · Cited by 1
Nutritional Status and CD4 Cell Counts in Patients with HIV/AIDS Receiving Antiretroviral Therapy
Almeida, A. M. R., & dos Santos, A. C. O. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800769-3.00014-7 · Cited by 1
Rivero, A., Pèc)rez-Molina, J. A., Blasco, A. J., Arribas, J. R., Asensi, V., Casal, M. C., Domingo, P., Iribarren, J. A., Lázaro, P., López-Aldeguer, J., et al. (2018) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2017.04.014 · Cited by 1
Antibiotika und Chemotherapeutika
Kern, W. V. (2011) · Springer eBooks · doi:10.1007/978-3-642-21992-4_9 · Cited by 1
Antibiotika und Chemotherapeutika
Kern, W. V. (2016) · Springer eBooks · doi:10.1007/978-3-662-50351-5_12 · Cited by 1
Antibiotika und Chemotherapeutika
Kern, W. V. (2012) · Springer eBooks · doi:10.1007/978-3-642-29242-2_9 · Cited by 1
Aleebrahim, F., Nasirian, M., & Ramezani, A. (2023) · HIV & AIDS Review · doi:10.5114/hivar.2023.126543 · Cited by 1
Borchmann, O. B., Weis, N. M., Hansen, A. E., Storgaard, M., Fetters, M. D., Chandanabhumma, P. P., & Moseholm, E. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-077303 · Cited by 1
Self-citationHIV Diagnostic Algorithms in A Resource-Limited Setting: A Comparative Study
Fasakin, K. A., Ajayi, O. D., Ibijola, A. A., Adeniyi, A. A., Ajetunmobi, W. A., Ajetunmobi, O. A., Adewara, O. E., Bakare, A., & Oyegue, B. E. (2024) · Journal of Advances in Medical and Pharmaceutical Sciences · doi:10.9734/jamps/2024/v26i7703 · Cited by 1
Development of the First AIDS Drugs: AZT and Other Dideoxynueosides
Yarchoan, R., & Mitsuya, H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7291-9_1 · Cited by 1
Overview of antiretroviral therapy
Coffey, S., & Volberding, P. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0695-2.00011-0 · Cited by 1
HIV, hepatitis viruses and viral STIs: intertwined fates?
Cunningham, T. (2014) · Microbiology Australia · doi:10.1071/ma14025 · Cited by 1
HIV service capacity: identifying current and future areas of clinical shortage
Mallitt, K., Jansson, J., Wand, H. C., Crooks, L., & Wilson, D. P. (2013) · Sexual Health · doi:10.1071/sh13151 · Cited by 1
Die Bedeutung der subjektiven Perspektive auf die Behandlung von HIV
Gaab, J. (2010) · Zeitschrift für Gesundheitspsychologie · doi:10.1026/0943-8149/a000003 · Cited by 1
Money, D., Tulloch, K. J., Boucoiran, I., Caddy, S. C., Yudin, M. H., Allen, V. M., Bouchard, C., Boucher, M., Boucoiran, I., Caddy, S. C., et al. (2014) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30516-8 · Cited by 1
[Current status and overview of HIV/AIDS infection].
Honda, M. (2012) · Nippon Jibiinkoka Gakkai Kaiho · doi:10.3950/jibiinkoka.115.759 · Cited by 1
Antibiotika und antibakterielle Chemotherapeutika
Kern, W. V. (2018) · Springer eBooks · doi:10.1007/978-3-662-57386-0_12 · Cited by 1
Gulick, R. M. (2009) · doi:10.1002/9783527627905.ch4 · Cited by 1
¿Influye el coste de los medicamentos en la elección de las pautas del tratamiento antirretroviral?
Rivero, A. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.10.007 · Cited by 1
HIV diagnosis and antiretroviral therapy
Zuckerman, M. A., & Pillay, D. (2008) · Medicine · doi:10.1016/j.mpmed.2007.12.011 · Cited by 1
Serious non-AIDS conditions: redefining the spectrum of HIV-related disease.
Baker, J. V., & Henry, K. (2007) · PubMed · Cited by 1
Álvarez-Álvarez, B., Prieto-Pérez, L., de la Cuadra-Grande, A., Casado, M. Á., Cabello, A., Al‐Hayani, A., Acosta, I. C., Mahíllo, I., Hernández-Mora, M. G., Rallón, N. I., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3845263/v1 · Cited by 1
HIV/Aids Relative Survival and Mean Residual Life Analysis
Zhang, X. (2022) · Digital Archive @ GSU · doi:10.57709/1059699 · Cited by 1
Gennembrud inden for farmakoterapi
Gerstoft, J., Lundgren, J. D., Obel, N., & Instituttet, P. (2009)
Self-citationGiddy, L. A. (2009) · SUNScholar (Stellenbosch University)
Williams, J. P., Fidler, S. J., & Frater, J. (2011) · InTech eBooks · doi:10.5772/22942
Sevastianova, K. (2011) · Työväentutkimus Vuosikirja
Patientin mit organischem Psychosyndrom und neurologischen Herdzeichen unter Immunsuppression
Kühnlein, P., Ringhoffer, M., Tumani, H., & Gdynia, H.-J. (2007) · Der Internist · doi:10.1007/s00108-007-1983-x
Wasting Diseases and Metabolic Impact on Bone: Emerging Therapeutics and Treatment Options
DiMeglio, L. A. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2745-1_11
Wright, J., Brockman, M. A., Brumme, Z. L., Walker, B. D., Goulder, P., & Ndung’u, T. (2009) · Retrovirology · doi:10.1186/1742-4690-6-s3-p122
HIV and Aging: An Evolving Challenge for the Oil and Gas Industry
Battalora, L. A., Spear, J. R., & Young, B. (2012) · All Days · doi:10.2118/158121-ms
Association of Highly Active Antiretroviral Treatment for HIV Disease and Metabolic Issues
Kolpepaj, R., Shkurti, E., Nake, A., Harxhi, A., Kolici, E., & Capi, K. (2015) · Academic Journal of Interdisciplinary Studies · doi:10.5901/mjss.2015.v4n1p153
Rogowska-Szadkowska, D., Chlabicz, S., & Marzec-Bogusławska, A. (2010) · HIV & AIDS Review · doi:10.1016/s1730-1270(10)60092-6
Inflammation and innate immune activation in chronic HIV infection
Jaworowski, A., & Hearps, A. C. (2014) · Microbiology Australia · doi:10.1071/ma14032
Wohl, D. A., Kendall, M. A., Feinberg, J., Alston‐Smith, B., Owens, S., Chafey, S., Marco, M., Maxwell, S., Benson, C. A., Keiser, P. H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078676
Disfunción ventricular izquierda en pacientes con infección por virus de inmunodeficiencia humana
Martín, A. V., & Pérez, A. M. R. (2013) · CorSalud
Igumbor, J. O. (2012) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Omura, K., & Tsuchiya, S. (2012) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2012-435
Untreated HIV: harmful even at high CD4 cell counts
Hausenloy, D. J., Opie, L. H., & Yellon, D. M. (2010)
PRIMARY CARE GUIDELINES FOR THE MANAGEMENT OF HIV/AIDS
Columbia, I. B. (2011)
Life Expectancy with HIV: Increasing but Not Normal
Saitz, R., FACP., F., & Fasam (2007) · Journal watch · doi:10.1056/jw200701300000005
Chapter 3 Future of HIV/AIDS Care in Low- and Middle- Income Countries
Hoffmann, C. J., Mills, L. A., & Gallant, J. E. (2008)
Research for the facilitation of dialysis therapy in HIV-infected patients:
Akiba, T., Hinoshita, F., & Imamura, A. (2013) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.46.931
CD4+ T-cell Count Prior to Antiretroviral Therapy Predicts Post-Therapy Immune Reconstitution
Uchiumi, H., Ogawa, Y., Yanagisawa, K., Gohda, F., Ogura, H., Mawatari, M., Sawamura, M., & Nojima, Y. (2011) · The Kitakanto Medical Journal · doi:10.2974/kmj.61.281
Survival in HIV-Infected Patients
del Rı́o, C. (2007) · Journal watch · doi:10.1056/ac200703120000002
Cardio-metabolic effects of anti-retroviral treatment in the Cape Winelands region of South Africa
Abaid, F. E. B. (2016) · SUNScholar (Stellenbosch University)
7. Recent Trend of HIV Infection.
Oka, S. (2011) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.100.2626
6. Current Status of Development of Anti HIV Drug and Future Prospect of Combination Treatment
Oka, S. (2009) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.98.2809
Imamura, A. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.2816
Metadata
- Authors
- Lohse, N., Hansen, A.-B. E., Pedersen, G., Kronborg, G., Gerstoft, J., Sørensen, H. T., Væth, M., & Obel, N.
- Affiliations
- Boston University (US)
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2007-01-16
- Volume
- 146
- Issue
- 2
- Pages
- 87-95
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1967548282
- Cited by
- 748
- References
- 21
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 15 · 2023: 9 · 2022: 14 · 2021: 17 · 2020: 19 · 2019: 15 · 2018: 34 · 2017: 32 · 2016: 44 · 2015: 54 · 2014: 62 · 2013: 75 · 2012: 73
- FWCI
- 39.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- HIV infection, survival, mortality, age-specific mortality, excess mortality, hepatitis C coinfection, highly active antiretroviral therapy, HIV cohort, Denmark, life tables, HIV treatment outcomes
- MeSH terms
- Adult, Cause of Death, Denmark, Female, Hepatitis C, Humans, Life Expectancy, Male, Middle Aged, Prospective Studies, HIV Infections, Survival Rate, Case-Control Studies, Antiretroviral Therapy, Highly Active
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review